Humacyte Stock Forecast

Stock Price Forecast

According to 5 analysts polled by S&P Global, Humacyte stock has a consensus rating of "Buy" and an average price target of $2.05. The average 1-year stock price forecast is 211.27% higher than the current stock price, while the lowest is $1.00 (+51.84%) and the highest is $4.00 (+507.35%).

Price Target: $2.05 (+211.27%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$2.05	$2.00	$4.00
Change	+51.84%	+211.27%	+203.67%	+507.35%

Analyst Ratings

The average analyst rating for Humacyte stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '26	Feb '26	Mar '26	Apr '26	May '26	Jun '26
Strong Buy	5	5	4	4	3	3
Buy	1	1	2	2	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	7	7	7	5	5

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Allison Bratzel Piper Sandler	Piper Sandler	Hold Maintains $1	Hold	Maintains	$1	+51.84%	Jun 18, 2026
Josh Jennings TD Cowen	TD Cowen	Buy Reiterates $1.5 → $1.25	Buy	Reiterates	$1.5 → $1.25	+89.80%	Jun 17, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $4	Buy	Reiterates	$4	+507.35%	Jun 11, 2026
Bruce Jackson Benchmark Co.	Benchmark Co.	Buy Maintains $1 → $2	Buy	Maintains	$1 → $2	+203.67%	Jun 1, 2026
Matt Miksic Barclays	Barclays	Buy Reiterates $1.5	Buy	Reiterates	$1.5	+127.76%	May 14, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

6.34M

from 2.04M

211.26%

from 2.04M

Revenue Next Year

26.31M

from 6.34M

314.69%

from 6.34M

EPS This Year

-0.35

from -0.26

EPS Next Year

-0.24

from -0.35

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	1.26M	1.57M	-	-	2.04M	6.34M
Revenue Growth	-15.29%	23.91%	-	-	-	211.26%
Gross Profit	-60.08M	-61.70M	-76.55M	-88.60M	-76.37M	2.11M
Gross Margin	-4,756.77%	-3,942.17%	-	-	-3,747.11%	33.27%
Operating Income	-81.21M	-84.58M	-96.94M	-114.40M	-107.44M	-87.53M
Net Income	-26.48M	-11.97M	-110.78M	-148.70M	-40.83M	-78.35M
EPS	-	-	-	-	-0.26	-0.35
Free Cash Flow	-34.63M	-40.66M	-45.28M	-65.36M	-71.89M	-52.00M
No. Analysts	-	-	-	-	-	5

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	8.4M
Avg	6.3M
Low	4.4M

Revenue Growth

Revenue Growth	2026	2027	2028
High	311.1%
Avg	211.3%
Low	114.4%

EPS Forecast

EPS	2026	2027	2028
High	-0.32
Avg	-0.35
Low	-0.37

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-